Citations

Showing 10 of 108162 citations.

Favorable Hemocompatibility in HeartMate 3 May Prevent Thrombosis After Prolonged Pump Cessation
Rohm, Charlene, Howard, Brian , Lakhani, Baqir, Luu, Theresa, Snipelisky, David, Rohm, Charlene L. , Howard, Brian , Lakhani, Baqir, Luu, Theresa, Snipelisky, David

Mayo Clinic

ASAIO Journal | March 26, 2021 | Volume: 68 | Issue: 2 | Pages: e27-e28

10.1097/mat.0000000000001416 | PMID 33769351 Get It

The HeartMate 3 Left Ventricular Assist System has demonstrated a reduction in risk of pump thrombosis. The improved hemocompatibility of this device is largely attributed to the pump mechanics including a large-diameter outflow graft, increased retrograde flow through the pump during pump cessation, and the textured blood-contacting surfaces of the pump. We present a 55-year-old man with a HeartMate 3 device who presented with heart failure symptoms, prolonged pump cessation for 7 days, and subtherapeutic anticoagulation therapy. Despite prolonged pump cessation and interrupted anticoagulation therapy, there was no evidence of pump thrombosis as determined by both laboratory and imaging studies. This case suggests favorable hemocompatibility of the HeartMate 3 device, which clinicians may consider in the management of patients needing advanced therapies.
Expert Commentary on Adult Intussusception
Mathis, Kellie L.

Mayo Clinic

Diseases of the Colon & Rectum | March 26, 2021 | Volume: 64 | Issue: 6 | Pages: 648-649

10.1097/dcr.0000000000002043 | PMID 33769325 Get It

Novel splicing (c.6529-1G>T) and missense (c.1667G>A) mutations causing factor V deficiency
Ayala, Sofia Saenz, Hu, Xiaolin , Chang, Simone , Sharma, Vivek R. , Majerus, Julie A. , Pruthi, Rajiv K. , Pruthi, Rajiv, Maharaj, Satish Stephen , Hu, Xiaolin

Mayo Clinic

Blood Coagulation & Fibrinolysis | March 26, 2021 | Volume: 32 | Issue: 5 | Pages: 344-348

10.1097/mbc.0000000000001036 | PMID 33769317 Get It

Congenital factor V deficiency (FVD) is a rare bleeding disorder. In this study, we investigated the genetic basis in an African American patient with factor V activity 3%. Custom sequence capture and targeted next-generation (NGS) sequencing of the F5 gene were undertaken followed by PCR and Sanger sequencing. Two novel variants were identified. In silico analyses correlated clinically with the patient's factor V activity and hemorrhagic tendency. A review of the literature regarding these genomic alterations is presented. We described two novel mutations causing moderate FVD. The first, Chr1:g.169483698C>A with cDNA change (F5):c.6529-1G>T, occurred in a conserved nucleotide at the canonical acceptor splice site of intron 24. The second, Chr1:g.169515775C>T with cDNA change (F5):c.1667G>A, was a missense variant of exon 11, affecting a highly conserved amino acid in the A2 domain. Further research into the mechanisms of F5 mutations leading to FVD and residual factor V expression are needed.
Current Parental Leave Policies for Medical Students at U.S. Medical Schools: A Comparative Study
Kraus, Molly B. , Talbott, Jennifer , Melikian, Ryan, Merrill, Sarah , Stonnington, Cynthia M. , Files, Julia A. , Kouloumberis, Pelagia , Talbott, Jennifer M V, Merrill, Sarah A, Kouloumberis, Pelagia E, Kraus, Molly B , Talbott, Jennifer M V , Hayes, Sharonne N.

Mayo Clinic

Academic Medicine | March 26, 2021 | Volume: 96 | Issue: 9 | Pages: 1315-1318

10.1097/acm.0000000000004074 | PMID 33769337 Get It

Purpose Parental leave for new parents is essential as they adjust to the physical and psychological changes that accompany childbirth and caring for a newborn. This study sought to determine the current state of parental leave policies for medical students at medical schools in the United States. Method From November to December 2019, 2 researchers independently reviewed the websites of 199 U.S. MD-granting and DO-granting medical schools (including in U.S. territories). Online student handbooks and school webpages were searched for the following keywords: “pregnant” OR “pregnancy” OR “maternity” OR “parent” OR “family” OR “child” OR “birth.” Data were analyzed using descriptive statistics. Fisher’s exact tests evaluated differences in proportion by group. Results Of 199 schools, 65 (32.66%) had parental leave policies available online or in the handbook: 39 of 155 (25.16%) MD-granting and 26 of 44 (59.09%) DO-granting schools. Of those policies, 59 (90.77%) were included in the student handbook. Most policies (28, 43.08%) were included as an option within the school’s general leave of absence policy. Both parents were included in 38 (58.46%) policies; 23 (35.38%) policies mentioned only mothers; and 4 (6.15%) were unknown. An option to maintain original graduation date was offered in 21 (32.1%) schools’ policies. Three schools (4.62%) included adoption as qualifying for parental leave. When comparing MD and DO programs, DO programs were statistically more likely to have a parental leave policy: 39 (25.16%) vs 26 (59.09%); P < .001. Conclusions Balancing medical school with pregnancy and childbirth necessitates administrative support to address the inherent scheduling challenges. Currently, many schools lack parental leave policies for medical students that are easily accessible, are separate from formal leaves of absence, allow for at least 12 weeks, and are tailored to the student academic year to ensure on-time completion of medical education.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Clostridioides difficile Infection
Boutros, Marylise , Khanna, Sahil , Paquette, Ian M., Poylin, Vitaliy Y. , Hawkins, Alexander T. , Bhama, Anuradha R. , Lightner, Amy L. , Feingold, Daniel L.

Mayo Clinic

Diseases of the Colon & Rectum | March 26, 2021 | Volume: 64 | Issue: 6 | Pages: 650-668

10.1097/dcr.0000000000002047 | PMID 33769319 Get It

Editorial: Salvage therapy in uro-oncology
Heidenreich, Axel , Karnes, R. Jeffrey

Mayo Clinic

Current Opinion in Urology | March 26, 2021 | Volume: 31 | Issue: 3 | Pages: 177

10.1097/mou.0000000000000876 | PMID 33769409 Get It

Alterations of Amphetamine Reward by Prior Nicotine and Alcohol Treatment: The Role of Age and Dopamine
Stojakovic, Andrea , Ahmad, Syed Muzzammil , Lutfy, Kabirullah , Stojacovic, Andrea

Mayo Clinic

Brain Sciences | March 26, 2021 | Volume: 11 | Issue: 4 | Pages: 420

10.3390/brainsci11040420 | PMID 33810331 Get It

Evidence suggests that nicotine and alcohol can each serve as a gateway drug. We determined whether prior nicotine and alcohol treatment would alter amphetamine reward. Also, we examined whether age and dopaminergic neurotransmission are important in this regard. Male and female adolescent and adult C57BL/6J mice were tested for baseline place preference. Mice then received six conditioning with saline/nicotine (0.25 mg/kg) twice daily, followed by six conditioning with saline/ethanol (2 g/kg). Control mice were conditioned with saline/saline throughout. Finally, mice were conditioned with amphetamine (3 mg/kg), once in the nicotine-alcohol-paired chamber, and tested for place preference 24 h later. The following day, mice were challenged with amphetamine (1 mg/kg) and tested for place preference under a drugged state. Mice were then immediately euthanized, their brain removed, and nucleus accumbens isolated and processed for the level of dopamine receptors and transporter and glutamate receptors. We observed a greater amphetamine-induced place preference in naïve adolescents than adult mice with no change in state-dependent place preference between the two age groups. In contrast, amphetamine induced a significant place preference in adult but not adolescent mice with prior nicotine-alcohol exposure under the drug-free state. The preference was significantly greater in adults than adolescents under the drugged state. The enhanced response was associated with higher dopamine-transporter and D1 but reduced D2 receptors’ expression in adult rather than adolescent mice, with no changes in glutamate receptors levels. These results suggest that prior nicotine and alcohol treatment differentially alters amphetamine reward in adult and adolescent mice. Alterations in dopaminergic neurotransmission may be involved in this phenotype.
How to Help Your Patients Enroll in the New-Onset Refractory Status Epilepticus (NORSE) and Febrile Infection-Related Epilepsy Syndrome (FIRES) Family Registry, and Other Rare Epilepsy Registries
Kazazian, Karnig , Wong, Nora , Eschbach, Krista , Moeller, Raquel Farias, Gaspard, Nicolas , Hocker, Sara E. , Hocker, Sara, Eschbach, Krista , Kazazian, Karnig , Gaspard, Nicolas , Kellogg, Marissa , Wong, Nora, Hirsch, Lawrence J. , Gofton, Teneille

Mayo Clinic

Epilepsy Currents | March 26, 2021 | Volume: 21 | Issue: 5 | Pages: 382-384

10.1177/15357597211002869 | PMID 33769129 Get It

Intracranial microhemorrhages in the setting of COVID-19: what we know so far
Benson, John C. , Klaas, James P. , Kallmes, David F. , Benson, John , Hunt, Christopher H.

Mayo Clinic

The Neuroradiology Journal | March 26, 2021 | Volume: 34 | Issue: 5 | Pages: 435-439

10.1177/19714009211004144 | PMID 33765876 Get It

Background Diffuse intracranial susceptibility abnormalities have recently been described among patients with coronavirus disease 2019 (COVID-19), although prior studies have consisted of case reports and/or series. This brief literature review seeks to compile and catalogue the available data to elucidate characteristic features of such findings. Materials and methods Scientific articles and studies on intracranial microhemorrhages in the setting of COVID-19 were searched on PubMed, Google Scholar, and the Cochrane Library. Included studies described intracranial microbleed(s) on magnetic resonance imaging in patients with COVID-19. If multiple patients were described, only patients with intracranial microhemorrhage on magnetic resonance imaging were included for analysis. Patient demographics, severity of illness (e.g. intensive care unit admission and/or intubation), time from diagnosis of COVID-19 to magnetic resonance imaging, and location(s) of any observed microhemorrhages were noted. Results A total of 39 patients with suspected intracranial microhemorrhages have been described in prior studies. The average age of patients was 64.7 years; 21.9% were women. The average time between COVID-19 diagnosis and magnetic resonance imaging was 31.7 days. All patients in the cohort were admitted to critical care and were either intubated or treated with extracorporeal membrane oxygenation during their clinical course. Microhemorrhages were most commonly located in the subcortical/juxtacortical white matter and corpus callosum. Conclusions Intracranial microbleeds are a well-documented finding in patients with severe COVID-19, and are most commonly callosal and subcortical/juxtacortical in location.